Plant Kunitz Inhibitors and Their Interaction with Proteases: Current and Potential Pharmacological Targets. 2022

Camila Ramalho Bonturi, and Ana Beatriz Silva Teixeira, and Vitória Morais Rocha, and Penélope Ferreira Valente, and Juliana Rodrigues Oliveira, and Clovis Macêdo Bezerra Filho, and Isabel Fátima Correia Batista, and Maria Luiza Vilela Oliva
Departamento de Bioquímica, Universidade Federal de São Paulo, Escola Paulista de Medicina, Rua Três de Maio, 100, São Paulo 04044-020, SP, Brazil.

The action of proteases can be controlled by several mechanisms, including regulation through gene expression; post-translational modifications, such as glycosylation; zymogen activation; targeting specific compartments, such as lysosomes and mitochondria; and blocking proteolysis using endogenous inhibitors. Protease inhibitors are important molecules to be explored for the control of proteolytic processes in organisms because of their ability to act on several proteases. In this context, plants synthesize numerous proteins that contribute to protection against attacks by microorganisms (fungi and bacteria) and/or invertebrates (insects and nematodes) through the inhibition of proteases in these organisms. These proteins are widely distributed in the plant kingdom, and are present in higher concentrations in legume seeds (compared to other organs and other botanical families), motivating studies on their inhibitory effects in various organisms, including humans. In most cases, the biological roles of these proteins have been assigned based mostly on their in vitro action, as is the case with enzyme inhibitors. This review highlights the structural evolution, function, and wide variety of effects of plant Kunitz protease inhibitors, and their potential for pharmaceutical application based on their interactions with different proteases.

UI MeSH Term Description Entries
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D010944 Plants Multicellular, eukaryotic life forms of kingdom Plantae. Plants acquired chloroplasts by direct endosymbiosis of CYANOBACTERIA. They are characterized by a mainly photosynthetic mode of nutrition; essentially unlimited growth at localized regions of cell divisions (MERISTEMS); cellulose within cells providing rigidity; the absence of organs of locomotion; absence of nervous and sensory systems; and an alternation of haploid and diploid generations. It is a non-taxonomical term most often referring to LAND PLANTS. In broad sense it includes RHODOPHYTA and GLAUCOPHYTA along with VIRIDIPLANTAE. Plant
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D005658 Fungi A kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies. Fungi, Filamentous,Molds,Filamentous Fungi,Filamentous Fungus,Fungus,Fungus, Filamentous,Mold
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D057057 Serine Proteases Peptide hydrolases that contain at the active site a SERINE residue involved in catalysis. Serine Proteinases,Serine Protease,Serine Protein Hydrolases,Serine Proteinase,Protease, Serine,Proteases, Serine,Protein Hydrolases, Serine,Proteinase, Serine,Proteinases, Serine

Related Publications

Camila Ramalho Bonturi, and Ana Beatriz Silva Teixeira, and Vitória Morais Rocha, and Penélope Ferreira Valente, and Juliana Rodrigues Oliveira, and Clovis Macêdo Bezerra Filho, and Isabel Fátima Correia Batista, and Maria Luiza Vilela Oliva
January 2006, Current medicinal chemistry,
Camila Ramalho Bonturi, and Ana Beatriz Silva Teixeira, and Vitória Morais Rocha, and Penélope Ferreira Valente, and Juliana Rodrigues Oliveira, and Clovis Macêdo Bezerra Filho, and Isabel Fátima Correia Batista, and Maria Luiza Vilela Oliva
January 1982, Pathobiology annual,
Camila Ramalho Bonturi, and Ana Beatriz Silva Teixeira, and Vitória Morais Rocha, and Penélope Ferreira Valente, and Juliana Rodrigues Oliveira, and Clovis Macêdo Bezerra Filho, and Isabel Fátima Correia Batista, and Maria Luiza Vilela Oliva
October 2023, Plants (Basel, Switzerland),
Camila Ramalho Bonturi, and Ana Beatriz Silva Teixeira, and Vitória Morais Rocha, and Penélope Ferreira Valente, and Juliana Rodrigues Oliveira, and Clovis Macêdo Bezerra Filho, and Isabel Fátima Correia Batista, and Maria Luiza Vilela Oliva
January 2010, Current topics in medicinal chemistry,
Camila Ramalho Bonturi, and Ana Beatriz Silva Teixeira, and Vitória Morais Rocha, and Penélope Ferreira Valente, and Juliana Rodrigues Oliveira, and Clovis Macêdo Bezerra Filho, and Isabel Fátima Correia Batista, and Maria Luiza Vilela Oliva
January 2003, Biochemical Society symposium,
Camila Ramalho Bonturi, and Ana Beatriz Silva Teixeira, and Vitória Morais Rocha, and Penélope Ferreira Valente, and Juliana Rodrigues Oliveira, and Clovis Macêdo Bezerra Filho, and Isabel Fátima Correia Batista, and Maria Luiza Vilela Oliva
January 2016, Current pharmaceutical design,
Camila Ramalho Bonturi, and Ana Beatriz Silva Teixeira, and Vitória Morais Rocha, and Penélope Ferreira Valente, and Juliana Rodrigues Oliveira, and Clovis Macêdo Bezerra Filho, and Isabel Fátima Correia Batista, and Maria Luiza Vilela Oliva
May 2016, European journal of pharmacology,
Camila Ramalho Bonturi, and Ana Beatriz Silva Teixeira, and Vitória Morais Rocha, and Penélope Ferreira Valente, and Juliana Rodrigues Oliveira, and Clovis Macêdo Bezerra Filho, and Isabel Fátima Correia Batista, and Maria Luiza Vilela Oliva
September 2020, Pharmaceuticals (Basel, Switzerland),
Camila Ramalho Bonturi, and Ana Beatriz Silva Teixeira, and Vitória Morais Rocha, and Penélope Ferreira Valente, and Juliana Rodrigues Oliveira, and Clovis Macêdo Bezerra Filho, and Isabel Fátima Correia Batista, and Maria Luiza Vilela Oliva
March 2004, Current drug targets. Infectious disorders,
Camila Ramalho Bonturi, and Ana Beatriz Silva Teixeira, and Vitória Morais Rocha, and Penélope Ferreira Valente, and Juliana Rodrigues Oliveira, and Clovis Macêdo Bezerra Filho, and Isabel Fátima Correia Batista, and Maria Luiza Vilela Oliva
September 1985, Nihon Geka Gakkai zasshi,
Copied contents to your clipboard!